Salvage craniospinal irradiation for recurrent intracranial germinoma: a single institution analysis
Authors:
Open Access
- 5 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 64 (2) , 428-437
Abstract
This study investigated the effectiveness and safety of low-dose salvage craniospinal irradiation (CSI) for recurrent germinoma. We retrospectively reviewed long-term tumor control and late adverse effects in 15 recurrent germinoma patients treated at our hospital between 1983 and 2019. Following the first recurrence of germinoma, seven were treated with 24–30 Gy of salvage CSI, three underwent non-CSI, and five were treated with only chemotherapy. CSI achieved a significantly better recurrence-free survival rate after the first recurrence compared to other strategies (100% vs 33%, p < 0.001: log-rank test). To evaluate the safety of salvage CSI, we assessed the outcomes at the final follow-up of seven patients who received salvage CSI at first recurrence and three patients who received salvage CSI at second recurrence. The median follow-up period was 220 months after initial treatment. Five patients who received 40–50 Gy of radiation therapy or underwent multiple radiation therapy before salvage CSI were classified into Group A, whereas five patients treated with platinum-based chemotherapy and 24–32 Gy of radiation therapy to the primary site, whole ventricle, or whole brain were classified into Group B. In Group A, one had endocrine dysfunction and the other had visual dysfunction. None were socially independent. Meanwhile, in Group B, no endocrine or visual dysfunction was found, and three patients were socially independent. Salvage CSI achieved excellent tumor control in recurrent germinoma and was safe in patients initially treated with low-dose radiation therapy and chemotherapy.Keywords
This publication has 42 references indexed in Scilit:
- Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced‐dose and volume irradiationPediatric Blood & Cancer, 2011
- Optimal treatment strategy for intracranial germ cell tumors: a single institution analysisJournal of neurosurgery. Pediatrics, 2009
- Germ cell tumors in the basal ganglia: problems of early diagnosis and treatmentJournal of neurosurgery. Pediatrics, 2008
- Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinomaPediatric Blood & Cancer, 2008
- Reirradiation Tolerance of the Human BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Endocrine Outcomes for Children With Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy With Stem-Cell Rescue on the SJMB-96 TrialJournal of Clinical Oncology, 2008
- Stereotactic Radiosurgery Followed by Whole Ventricular Irradiation for Primary Intracranial Germinoma of the Pineal Regionmin - Minimally Invasive Neurosurgery, 2005
- Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell TumorsJournal of Clinical Oncology, 2004
- Salvage therapy for recurrent germinomas in the central nervous systemBritish Journal Of Neurosurgery, 1999
- Growth and Growth Hormone Secretion After Treatment for Acute Lymphoblastic Leukemia in ChildhoodJournal of Pediatric Hematology/Oncology, 1995